Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
- DOI
- 10.1093/jnci/djag393
- Published
- 2026 Oct 19
- Container
- Journal of the National Cancer Institute
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/jnci/djag393,
title = {Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.},
author = {Colace SI and Pommert L and Leger KJ and Rushing T and Crews KR and Annesley C and Bernhardt MB and Ramsey LB and Kaiser N and Bhojwani D and Wayne AS and Cooper TM and Rheingold SR and Place AE and Chang BH and Sulis ML and Pauly M and Gaynon PS and Sachdeva R and Schafer ES and Sabnis HS},
year = {2026},
journal = {Journal of the National Cancer Institute},
doi = {10.1093/jnci/djag393},
url = {https://doi.org/10.1093/jnci/djag393}
}RIS
TY - JOUR TI - Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. AU - Colace SI AU - Pommert L AU - Leger KJ AU - Rushing T AU - Crews KR AU - Annesley C AU - Bernhardt MB AU - Ramsey LB AU - Kaiser N AU - Bhojwani D AU - Wayne AS AU - Cooper TM AU - Rheingold SR AU - Place AE AU - Chang BH AU - Sulis ML AU - Pauly M AU - Gaynon PS AU - Sachdeva R AU - Schafer ES AU - Sabnis HS PY - 2026 JO - Journal of the National Cancer Institute DO - 10.1093/jnci/djag393 UR - https://doi.org/10.1093/jnci/djag393 ER -
APA
SI, C., L, P., KJ, L., T, R., KR, C., C, A., MB, B., LB, R., N, K., D, B., AS, W., TM, C., SR, R., AE, P., BH, C., ML, S., M, P., PS, G., R, S., ES, S., & HS, S. (2026). Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag393
Source records
- pubmed · retrieved 2026-11-10T18:05:12.644Z